DEFINING ALPHA- AND BETA-CELL CROSSTALK FOR THE TREATMENT AND PREVENTION OF DIABETES

$312,040FY2018Defense Health AgencyDOD

Cornell University, Ithaca NY

Investigators

DEFINING ALPHA- AND BETA-CELL CROSSTALK FOR THE TREATMENT AND PREVENTION OF DIABETES · GrantIndex